Items

Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)

T. Bochenek, V. Abilova, A. Alkan, B. Asanin, I. Beriain, Z. Besovic, P. Vella Bonanno, A. Bucsics, M. Davidescu, E. de Weerdt, N. Duborija-Kovacevic, J. Furst, M. Gaga, E. Gailite, J. Gulbinovic, E. Gurpinar, B. Hanko, V. Hargaden, T. Hotvedt, I. Hoxha, I. Huys, A. Inotai, A. Jakupi, H. Jenzer, R. Joppi, O. Laius, M. Lenormand, D. Makridaki, A. Malaj, K. Margus, V. Marković Peković, N. Miljkovic, J. de Miranda, S. Primozic, D. Rajinac, D. schwartz, R. Sebesta, S. Simoens, J. Slaby, L. Sović-Brkičić, T. Tesar, L. Tzirnis, E. Warminska, B. Godman, Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries, Frontiers in Pharmacology, Vol. 8, No. article 942, pp. 1 - 23, Jan, 2018
Are pharmacists’ good knowledge and awareness on antibiotic taken for granted ? The situation in Albania and future implications across countries (2018-06)

I. Hoxha, A. Malaj, B. Kraja, S. Bino, M. Oluka, V. Marković Peković, B. Godman, Are pharmacists’ good knowledge and awareness on antibiotic taken for granted ? The situation in Albania and future implications across countries, Journal of global antimicrobial resistance, Vol. 13, pp. 240 - 245, Jun, 2018
Pricing of oral generic cancer medicines in 25 European countries; findings and implications (2019-02)

B. Godman, A. Hill, S. Simoens, A. Kurdi, J. Gulbinovic, A. Margus, A. Timoney, D. Gotham, J. Wale, T. Bochenek, I. Hoxha, C. Rodrigues, C. Hierlander, A. Malaj, R. Sauremann, W. Hamelinck, Z. Mitkova, G. Petrova, O. Laius, C. Sermet, I. Langer, G. Selke, J. Yfantopoulos, R. Joppi, A. Jakupi, E. Poplavski, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. Valk, C. Hagen, A. Ringerud, R. Plisko, M. Wladysiuk, V. Marković Peković, N. Grubiša, T. Ponorac, I. Mardare, T. Novakovic, M. Parker, J. Fraeyman, D. Tomek, M. Obach Cortadellas, C. Zara, M. Juhasz-Haverinen, P. Skiold, S. McTaggart, A. Heycox, Pricing of oral generic cancer medicines in 25 European countries; findings and implications, Generics and Biosimilars Initiative Journal, Vol. 8, No. 2, pp. 49 - 70, Feb, 2019
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures (2021-01)

E. Moorkens, B. Godman, I. Huys, I. Hoxha, A. Malaj, S. Keuerleber, S. Stockinger, S. Mortenhuber, M. Dimitrova, K. Tachkov, L. Vlahović-Palčevski, V. Vlahović-Palčevski, G. Achniotou, J. Slaby, L. Popelkova, K. Kohoutova, D. Bartels, O. Laius, J. Martikainen, G. Selke, V. Kourafalos, E. Magnusson, R. Einarsdottir, R. Adams, R. Joppi, E. Allocati, A. Jakupi, A. Viksna, I. Greičiute-Kuprijanov, P. Vella Bonanno, V. Suttorp, O. Melien, R. Plisko, I. Mardare, D. Meshkov, T. Novakovic, J. Furst, C. Zara, V. Marković Peković, N. Grubiša, G. Befrits, R. Puckett, A. Vulto, The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures, Frontiers in Pharmacology, pp. 1 - 17, Jan, 2021
Variation in the prices of oncology medicines across Europe and the implications for the future (2021-02)

B. Godman, S. Simoens, A. Kurdi, G. Selke, J. Yfantopoulos, A. hill, J. Gulbinovic, A. Martin, A. Timoney, D. Gotham, J. Wale, T. Bochenek, I. Selke Krulichova, E. Allocati, I. Hoxha, A. Malaj, C. Hierlander, A. Nachtnebel, W. Hamelinck, Z. Mitkova, G. Petrova, O. Laius, C. Sermet, I. Langer, R. Joppi, A. Jakupi, E. Poplavski, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. de Valk, R. Plisko, M. Wladysiuk, V. Marković Peković, I. Mardare, T. Novakovic, M. Parker, J. Furst, D. Tomek, K. Banasova, M. Obach Cortadellas, C. Zara, C. Pontes, M. Juhasz-Haverinen, P. Skiold, S. McTaggart, D. Wong-Rieger, S. Campbell, R. Hill, Variation in the prices of oncology medicines across Europe and the implications for the future, Generics and Biosimilars Initiative Journal, Vol. 10, No. 2, pp. 72 - 82, Feb, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021-03)

B. Godman, A. Hill, S. Simoens, G. Selke, I. Selke Krulichova, C. Zampirolli, A. Martin, W. Oortwijn, A. Timoney, L. Gustafsson, L. Vončina, H. Kwon, J. Gulbinovic, D. Gotham, J. Wale, W. da Silva, T. Bochenek, A. Kurdi, E. Allocati, O. Ogunleye, J. Meyer, I. Hoxha, A. Malaj, C. Hierlander, R. Sauremann, W. Hamelinck, G. Petrova, O. Laius, I. Langner, J. Yfantopoulos, R. Joppi, A. Jakupi, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. de Valk, M. Wladysiuk, V. Marković Peković, I. Mardare, J. Furst, D. Tomek, M. Obach Cortadellas, C. Zara, C. Pontes, S. McTaggart, T. Laba, O. Melien, D. Wong-Rieger, S. Bae, R. Hill, Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 21, No. 4, pp. 527 - 540, Mar, 2021
Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries (2016-11)

T. Bochenek, B. Godman, A. Bucsics, E. de Weerdt, J. Furst, E. Gailite, T. Hotvedt, I. Huys, A. Inotai, R. Joppi, A. Malaj, K. Margus, V. Marković Peković, S. Simoens, J. Slaby, L. Sović-Brkičić, E. Gurpinar, P. Vella Bonanno, E. Warminska, A. Pilc, Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries, Value in Health, Voulme 19, Issue 7, pp. A445 - A445, Nov, 2016
Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries (2017-11)

I. Hoxha, A. Malaj, B. Kraja, S. Bino, M. Oluka, V. Marković Peković, B. Godman, Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries, Abstract Book, pp. 60 - 60, Nov, 2017

Items

Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)

Are pharmacists’ good knowledge and awareness on antibiotic taken for granted ? The situation in Albania and future implications across countries (2018-06)

Pricing of oral generic cancer medicines in 25 European countries; findings and implications (2019-02)

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures (2021-01)

Variation in the prices of oncology medicines across Europe and the implications for the future (2021-02)

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021-03)

Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries (2016-11)

Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries (2017-11)